Dr Reddy's Q3 net profit rises 11% to ₹1,378.9 crore

[Bilgin]

Dr Reddy's Q3 net profit rises 11% to ₹1,378.9 crore Domestic generics sales comprised 16% of global sales, with revenue of ₹1,180 crore, marking a 5% increase due to new product introductions in India